Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | 139,00 € | 236,30 € | 70,00 % |
| Neurocrine Bioscience | 28 | 0 | 7 | 0 | 126,15 € | 140,34 € | 11,25 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 19,72 € | 26,01 € | 31,88 % |
| United Therapeutics | 18 | 0 | 3 | 0 | 245,40 € | 288,66 € | 17,63 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | 38,00 € | 84,74 € | 123,01 % |
| Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | 10,09 € | 22,78 € | 125,72 % |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | 40,44 € | 50,33 € | 24,46 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 151,35 € | 184,76 € | 22,07 % |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | 212,20 € | 248,57 € | 17,14 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 361,00 € | 421,61 € | 16,79 % |
| Xencor Inc. | 10 | 1 | 2 | 0 | 22,60 € | 32,58 € | 44,15 % |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | 28,20 € | 41,81 € | 48,28 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | 31,00 € | 38,99 € | 25,77 % |
| Catalent Inc. | 2 | 0 | 0 | 0 | 51,71 € | 55,00 € | 6,36 % |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 100,15 € | - | - |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | 1,63 € | 3,70 € | 127,41 % |
| Novocure Ltd | 1 | 1 | 0 | 0 | 16,68 € | - | - |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | 4,98 € | 4,62 € | -7,25 % |